Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.11 - $15.59 $221 - $31,367
-2,012 Reduced 0.27%
747,027 $78,000
Q2 2022

Aug 12, 2022

BUY
$0.24 - $0.42 $4,256 - $7,448
17,735 Added 2.43%
749,039 $259,000
Q2 2021

Aug 13, 2021

BUY
$0.6 - $0.89 $117,471 - $174,248
195,785 Added 36.56%
731,304 $515,000
Q1 2021

May 12, 2021

BUY
$0.52 - $1.52 $158,054 - $462,004
303,950 Added 131.26%
535,519 $485,000
Q3 2020

Nov 13, 2020

BUY
$0.56 - $1.49 $21,468 - $57,120
38,336 Added 19.84%
231,569 $133,000
Q2 2020

Aug 13, 2020

BUY
$0.39 - $0.83 $75,360 - $160,383
193,233 New
193,233 $134,000
Q1 2018

May 15, 2018

SELL
$1.6 - $3.17 $143,905 - $285,112
-89,941 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$2.1 - $4.6 $188,876 - $413,728
89,941
89,941 $21,000

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About ORAGENICS INC


  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $40.7M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.